Idiopathic Pulmonary Fibrosis Latest Advances

Alveolar Type II Cell-derived MMP1 high basal cells promote destructive microcysts in idiopathic pulmonary fibrosis.

Journal: bioRxiv : the preprint server for biology

Published: January 23, 2026

New treatment for idiopathic pulmonary fibrosis.

Journal: The American journal of nursing

Published: January 22, 2026

Oral Nalbuphine in Idiopathic Pulmonary Fibrosis-Associated Cough: The CORAL Randomized Clinical Trial.

Journal: JAMA

Published: January 22, 2026

Qingzao Jiufei Decoction in the Regulation of TGF-β/Smad Signaling in Idiopathic Pulmonary Fibrosis.

Journal: Journal of visualized experiments : JoVE

Published: January 19, 2026

Segmentation and calculation of lung fibrosis in IPF mice by 2.5D UNet.

Journal: Biomedical physics & engineering express

Published: January 15, 2026

Investigational insights into the potential of angiotensin type II receptor agonists as therapeutics for idiopathic pulmonary fibrosis.

Journal: Expert opinion on investigational drugs

Published: January 12, 2026

Thoracic Ultrasound applicability in the assessment of patients with fibrosing interstitial lung diseases: a systematic review.

Journal: Ultraschall in der Medizin (Stuttgart, Germany : 1980)

Published: January 12, 2026

STL1267 Inhibits Myofibroblast Differentiation in a TGFβ1-Driven Human Lung Fibroblast Model.

Journal: American journal of physiology. Cell physiology

Published: January 09, 2026

Association of Pulse Dose Corticosteroids With Outcomes Among Patients With Acute Exacerbations of Idiopathic Pulmonary Fibrosis.

Journal: CHEST pulmonary

Published: January 08, 2026

Elastokines are Associated with a Poor Prognosis in Idiopathic Pulmonary Fibrosis.

Journal: Research square

Published: January 08, 2026

A Druggable Tumor Suppressor and Leukemic Stem Cell Marker.

Journal: bioRxiv : the preprint server for biology

Published: January 07, 2026

Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosis.

Journal: bioRxiv : the preprint server for biology

Published: January 07, 2026